The Role of Fibroscan in Assessment of Liver Fibrosis in Patients With Diabetes Mellitus and Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD)

被引：0
|
作者：
Menon, Raakhi [1 ]
Movva, Giri [1 ]
Garza, Devin [1 ]
Butt, Edward [1 ]
Zhang, Julia [1 ]
Khan, Kashif [1 ]
机构：
[1] Univ Texas Med Branch, Galveston, TX USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期
关键词：
D O I：
10.14309/01.ajg.0001036180.44221.bc
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1703
引用
收藏
页码：S1240 / S1240
页数：1
相关论文
共 50 条
  • [21] DEGREE OF METABOLIC DYSFUNCTION IS LINKED TO STEATOHEPATITIS (MASH), FIBROSIS, AND HIGHER CARDIOVASCULAR RISK IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
    Kim, David
    Abboud, Yazan
    Ismail, Mohamed
    Goyal, Ritik Mahaveer
    Pyrsopoulos, Nikolaos
    Kim, Hyunseok
    Hajifathalian, Kaveh
    Al-Khazraji, Ahmed
    HEPATOLOGY, 2024, 80 : S441 - S442
  • [22] ENHANCING TRADITIONAL FIBROSIS PREDICTION MODELS WITH MACHINE LEARNING IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
    Kim, David
    Qureshi, Imran
    Ismail, Mohamed
    Abboud, Yazan
    Pyrsopoulos, Nikolaos
    Kim, Hyunseok
    Hajifathalian, Kaveh
    Al-Khazraji, Ahmed
    HEPATOLOGY, 2024, 80 : S587 - S588
  • [23] Assessing Liver Fibrosis in Type 2 Diabetes Mellitus Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease: The Role of Non-invasive Scoring Systems and Associated Factors
    Naskar, Arindam
    Mondal, Agnibho
    Chatterjee, Rupak
    De, Ruchika D.
    Roy, Sasmit
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
  • [24] PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) AND SEVERE FIBROSIS HAVE WORSE EXECUTIVE FUNCTION PERFORMANCE
    Weinstein, Ali
    de Avila, Leyla
    Lam, Brian
    Stepanova, Maria
    Price, Jillian
    Escheik, Carey
    Gerber, Lynn
    Younossi, Zobair
    HEPATOLOGY, 2024, 80 : S827 - S828
  • [25] Dietary Influences on Gut Microbiota and Their Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Hamamah, Sevag
    Iatcu, Oana C.
    Covasa, Mihai
    NUTRIENTS, 2025, 17 (01)
  • [26] Liver Cell Mitophagy in Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis
    Chen, Jiaxin
    Jian, Linge
    Guo, Yangkun
    Tang, Chengwei
    Huang, Zhiyin
    Gao, Jinhang
    ANTIOXIDANTS, 2024, 13 (06)
  • [27] Metabolic dysfunction-associated steatotic liver disease-associated fibrosis and cardiac dysfunction in patients with type 2 diabetes
    Cernea, Simona
    Onisor, Danusia
    Roiban, Andrada Larisa
    Benedek, Theodora
    Rat, Nora
    WORLD JOURNAL OF CARDIOLOGY, 2024, 16 (10):
  • [28] ASSOCIATION BETWEEN CARDIOVASCULAR HEALTH AND METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
    Alebna, Pamela L.
    Yasin, Alhussain
    Harley, Kayla
    Ambrosio, Matthew
    Dixon, Dave L.
    Siddiqui, Mohammad
    Salloum, Fadi N.
    Mehta, Anurag
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 2029 - 2029
  • [29] Roles of Activin A and Gpnmb in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Liu, Huan
    Yerevanian, Armen
    Westerhoff, Maria
    Hastings, Margaret H.
    Guerra, Justin Ralph Baldovino
    Zhao, Meng
    Svensson, Katrin J.
    Cai, Bishuang
    Soukas, Alexander A.
    Rosenzweig, Anthony
    DIABETES, 2024, 73 (02) : 260 - 279
  • [30] Does Resveratrol Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)?
    Kasprzak-Drozd, Kamila
    Nizinski, Przemyslaw
    Kasprzak, Paulina
    Kondracka, Adrianna
    Oniszczuk, Tomasz
    Rusinek, Agata
    Oniszczuk, Anna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (07)
12345